Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

Japanese Generics Market Poised for Rapid Expansion

Feb 20, 2011
Share |
 

According to our latest report entitled Japanese Generic Market Forecast to 2013, the generic drugs market in Japan has been witnessing positive developments for the past few years. All the industry participants have been actively promoting the use of generic drugs across the country. Due to such positive developments, the generics market in Japan reached US$ 7.3 Billion in 2009 and the government support has been a key factor for this growth. In future, the expiry of branded drugs and active ingredients is likely to back market growth. Further, growing at the CAGR of around 8% during 2009-2013, total market value will be worth US$ 10 Billion by 2013 end.

Our report has found that there are many distribution channels in Japan, which are likely to collaborate with both private and public players to support promotional activities of generic drugs. A significant rise in the number of Diagnostic Procedure Combination (DPC) based hospitals has already proved to be a positive development for generics market and further proliferation is likely to boost revenue patterns. Private players are collaborating with many medical institutions and distributors to help them in dispensing their generic products.

The report Japanese Generic Market Forecast to 2013 provides an in depth research of Japanese generic drugs market and covers recent market trends that are affecting market structure. The report also analyzes the current generic drugs market size, its share in the overall pharmaceutical market in terms of value and volume, segments, key active players, and their market share. The overall pharmaceutical market has also been analyzed in the report.

Our report is an outcome of a prudent analysis and deep research of the overall generic drugs market in Japan. The report provides the forecast in key segments till the year 2013 and for projections, we have used effective methods and techniques. Coverage of key market players, their brief description, and recent developments seek to enhance knowledge regarding private sector participation. Overall, the report is a complete amalgamation of analysis, presentation, and statistics that add value to clients’ knowledge portfolio.

For more information visit: http://rncos.com/Report/IM170.htm


Related Press Releases:
» Neurological Drug Market to Grow at a CAGR of around 10% during 2011-2014
» Stupendous Growth Observed in Global Genetic Testing Market
» US Generics Market Poised for Stupendous Growth
» Antipsychotics to Drive the US Generics Market
» Rising Healthcare Costs Supporting Growth of the US Generics Industry
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports